Rang	Name	Position
1	Dr. Paul B. Bolno M.B.A., M.D.	President, CEO & Director
2	Dr. Gregory L. Verdine Ph.D.	Founder & Director
3	Mr. Kyle B. Moran CFA	CFO & Principal Accounting Officer
4	Dr. Chandra Vargeese Ph.D.	Chief Technology Officer
5	Dr. Christopher Francis Ph.D.	Senior VP of Corporate Development & Head of Emerging Areas
6	Dr. Erik Ingelsson M.D., Ph.D.	Chief Scientific Officer
7	Ms. Kate Rausch	Head of Investor Relations
8	Ms. Linda Rockett J.D.	Senior VP & General Counsel
9	Ms. Daryn Lewis	Senior VP & Head of Human Resources
10	Dr. Sridhar Vaddeboina M.B.A., Ph.D.	Senior Vice President of Chemistry, Manufacturing & Controls

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RA Capital Management, LLC	13,69%	123,82 Mio. USD
2	GSK PLC	9,26%	83,75 Mio. USD
3	BlackRock Inc	7,16%	64,80 Mio. USD
4	Maverick Capital Ltd	5,16%	46,64 Mio. USD
5	T. Rowe Price Associates, Inc.	4,42%	39,95 Mio. USD
6	Driehaus Capital Management LLC	2,76%	24,93 Mio. USD
7	PRIMECAP Management Company	2,72%	24,58 Mio. USD
8	FMR Inc	2,64%	23,84 Mio. USD
9	683 Capital Management LLC	2,49%	22,49 Mio. USD
10	M28 Capital Management LP	2,33%	21,06 Mio. USD
11	Two Sigma Investments LLC	1,88%	17,02 Mio. USD
12	State Street Corp	1,86%	16,86 Mio. USD
13	Geode Capital Management, LLC	1,82%	16,43 Mio. USD
14	Algert Global LLC	1,43%	12,93 Mio. USD
15	Siren, L.L.C.	1,24%	11,25 Mio. USD
16	Pfizer Inc	0,95%	8,61 Mio. USD
17	Millennium Management LLC	0,92%	8,31 Mio. USD
18	Marshall Wace Asset Management Ltd	0,91%	8,22 Mio. USD
19	D. E. Shaw & Co LP	0,90%	8,14 Mio. USD
20	Schroder Investment Management Group	0,89%	8,02 Mio. USD